pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
vitamin D3
Phase 1 · other · X-linked Adrenoleukodystrophy
vitamin D3 for X-linked Adrenoleukodystrophy is a Phase 1 program (other) at S.L with 1 ClinicalTrials.gov record(s).
Internal code 23596
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 1
- Modality
- other
- Indication
- X-linked Adrenoleukodystrophy
- Status
- completed
- Trials
- 1